
11. August 2021
Webinar by AYOXXA
Cytokine Release Syndrome and clinical implication of cytokine monitoring
Date and time
August 26th 2021 at 15:00-15:45 (GMT+2)
Program
Introduction
Cytokine Release Sydrome and clinical implication of cytokine monitoring:
- Short introduction of the term Cytokine Release Syndrome/Cytokine storm: pathophysiology, causes, CRS in the context of COVID-19
- Cytokine monitoring in CRS: Cytokine monitoring as an important parameter to detect, treat, prevent CRS and to distinguish it from efficient and strong immune reactions necessary to clear an infection
Introduction LUNARIS technology
- LUNARISTM technology principle: bead-based planar detection systemIntroduction to the LUNARISTM platform, kits, reader and software
Cases
Biomarker profiles are an important monitoring tool in the context of multiple diseases and therapeutic interventions such as:
- Graft-versus-host disease: biomarker signatures guiding treatment options
- CAR-T cell therapy: monitoring safety & efficacy in immune-oncology
- COVID-19: analyzing cytokine release after SARS-CoV-2-specific T cell activation
Q/A session
Webinar speaker
Ayoxxa’s Field Application Scientist, Dr. Alex Kiraly, is a biomedical scientist with over 15 years providing scientific, educational, and research support for groundbreaking research in Oncology, Immunology, and Rheumatology fields. Alex currently resides in Charlotte, North Carolina (US) and has been providing scientific support for over 2 years for Ayoxxa.
Registration
Register to this event via our Product Specialist Zuma Mahmood at zuma.mahmood@ramcon.dk